Silexion Therapeutics announces 1-for-9 reverse share split
Silexion Therapeutics (NASDAQ:SLXN) has announced a 1-for-9 reverse share split of its ordinary shares.The reverse share split will become effective after market close on November 27, 2024, and the company’s ordinary shares will begin trading on a split-adjusted basis on the Nasdaq Global Market at market open on November 29, 2024.The reverse share split is intended to enable SLXN to regain and maintain compliance with Nasdaq’s minimum bid price requirement.Source: Press Release
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.